MED8 抗体 (AA 1-59)
Quick Overview for MED8 抗体 (AA 1-59) (ABIN566700)
抗原
See all MED8 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-59
- 
                                            原理
- Mouse polyclonal antibody raised against a partial recombinant MED8.
- 
                                            序列
- MRQTEGRVPV FSHEVVPDHL RTKPDPEVEE QEKQLTTDAA RIGADAAQKQ IQSLNKMCS
- 
                                            交叉反应
- 人
- 
                                            产品特性
- Antibody Reactive Against Recombinant Protein.
- 
                                            免疫原
- MED8 (NP_443109, 1 a.a. ~ 59 a.a) partial recombinant protein with GST tag.
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 50 % glycerol
- 
                                            注意事项
- Aliquot to avoid repeated freezing and thawing.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
 
- 
                                            
- 
    - MED8 (Mediator Complex Subunit 8 (MED8))
- 
                                            别名
- MED8
- 
                                            背景
- 
                        Full Gene Name: mediator complex subunit 8
 Synonyms: ARC32,MGC17544,MGC19641
- 
                                            基因ID
- 112950
- 
                                            NCBI登录号
- NM_052877
- 
                                            途径
- Regulation of Lipid Metabolism by PPARalpha
 抗原
- 
                    
 
                                     
                                     
                                    